ClinVar Miner

Submissions for variant NM_007294.4(BRCA1):c.2416G>A (p.Ala806Thr) (rs80357144)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000047832 SCV000075845 likely benign Hereditary breast and ovarian cancer syndrome 2019-12-20 criteria provided, single submitter clinical testing
GeneDx RCV000212167 SCV000209939 likely benign not specified 2017-10-02 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Ambry Genetics RCV000218307 SCV000274017 likely benign Hereditary cancer-predisposing syndrome 2019-04-17 criteria provided, single submitter clinical testing In silico models in agreement (benign);Other data supporting benign classification
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000212167 SCV000698950 uncertain significance not specified 2019-05-03 criteria provided, single submitter clinical testing Variant summary: BRCA1 c.2416G>A (p.Ala806Thr) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 250528 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.2416G>A has been reported in the literature in individuals affected with breast cancer (e.g. Borg_2010) without strong evidence of causality. Therefore, these reports do not provide unequivocal conclusions about association of the variant with Hereditary Breast and Ovarian Cancer. In addition, a functional study reports that this variant has no impact on homologous recombination activity of BRCA1 protein (Lu_2015). Three submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation ((1x uncertain significance and 2x likely benign). Based on the evidence outlined above, the variant was classified as VUS - possibly benign until additional clinical and functional evidence becomes available.
Color Health, Inc RCV000218307 SCV000909344 likely benign Hereditary cancer-predisposing syndrome 2018-05-31 criteria provided, single submitter clinical testing
Sharing Clinical Reports Project (SCRP) RCV000077517 SCV000109318 likely benign Breast-ovarian cancer, familial 1 2009-04-30 no assertion criteria provided clinical testing
Breast Cancer Information Core (BIC) (BRCA1) RCV000077517 SCV000144423 uncertain significance Breast-ovarian cancer, familial 1 2001-10-29 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.